Riesgo oncológico e infección COVID-19 en mujeres usuarias de anticonceptivos hormonales.

Authors

  • Iván Enrique Naranjo Logroño Carrera de Medicina, Facultad de Salud Pública, Escuela Superior Politécnica de Chimborazo, Riobamba, Chimborazo, Ecuador https://orcid.org/0000-0002-4292-6499
  • Daniel Alberto Suárez Guerrero Centro de Salud 1. Distrito 06D01. Coordinación Zonal 3. Ministerio de Salud Pública del Ecuador, Riobamba, Chimborazo, Ecuador; código postal 060104, www.msp.gob.ec https://orcid.org/0000-0003-0170-4731
  • Cristian Alberto Zumárraga Pozo Ministerio de Salud Pública del Ecuador, Riobamba, Chimborazo, Ecuador; código postal 060104, www.msp.gob.ec https://orcid.org/0000-0002-1755-593X
  • Carla Victoria Sandoval Flores Ministerio de Salud Pública del Ecuador, San Lorenzo, Esmeraldas, Ecuador; código postal 080557, www.msp.gob.ec https://orcid.org/0000-0002-9814-1359
  • Karla Daniela Maldonado Guerrero Ministerio de Salud Pública del Ecuador, Riobamba, Chimborazo, Ecuador; código postal 060104, www.msp.gob.ec https://orcid.org/0000-0002-8128-8688

DOI:

https://doi.org/10.47187/cssn.Vol13.IssEd.Esp..185

Keywords:

anticonceptivos, anticonceptivos hormonales orales, infecciones por coronavirus, neoplasias

Abstract

Introduction: COVID-19 is the cause of several alterations in coagulation which can be increased by the use of contraceptives. Likewise, its administration is associated with an increased oncological risk for some cancers, but it has a certain level of protection against others. Oncology patients are at increased risk of COVID-19 infection, but no association between hormonal contraceptive use, COVID-19 and oncologic risk has been reported. Objective: To identify key characteristics of oncologic risk and COVID-19 infection among hormonal contraceptive users. Methods: A correlational, descriptive and systematic study, based on a review of 42 documents between the years 2020-2022, containing clear and concrete information on the subject, in English and Spanish. Results: Out of a total of 50 articles found, 42 documents were selected, in English and Spanish, that appropriately met the exclusion and inclusion criteria. Discussion: The provision of contraceptives should be done after evaluation of thromboembolic and oncologic risks. Patients with cancer have a greater predisposition to contract COVID-19 and present severe symptoms, but there is no evidence as to whether the use of contraceptives affects the presentation or prognosis of cancer in patients infected with this virus. Conclusions: There is no evidence to determine a correlation of increased cancer risk in patients using contraceptives with COVID-19 infection.

Downloads

Download data is not yet available.

Published

2022-09-05

How to Cite

Naranjo Logroño, I. E., Suárez Guerrero, D. A., Zumárraga Pozo, C. A., Sandoval Flores, C. V., & Maldonado Guerrero, K. D. (2022). Riesgo oncológico e infección COVID-19 en mujeres usuarias de anticonceptivos hormonales. LA CIENCIA AL SERVICIO DE LA SALUD Y NUTRICIÓN, 13(Ed.Esp.), B_125–135. https://doi.org/10.47187/cssn.Vol13.IssEd.Esp.185

Issue

Section

Artículos originales

Most read articles by the same author(s)

<< < 1 2 3